Overview
ACL Cables manufactures electrical cables, conductors and related electrical products for institutional, retail and export markets, supported by integrated production and distribution. The latest quarter shows a clear tension: sales and operating profit continued to grow, but weaker margins and larger costs below operating profit left the increase in earnings attributable to the business modest.
Price performance
ACL closed at LKR 102 on 13 November 2026. On the adjusted post-split basis, it rose 14.1% over one month against a 10.3% ASPI gain, and was up 36.5% over one year while the ASPI fell 4.7%; the share has therefore outpaced the wider market over both periods.
The price sat 82.4% of the way from its 52-week low to high, close to the top of its own annual range. Recent volatility was below its own one-year norm while 20-day volume was above the 60-day norm, indicating a quieter trading range alongside more active turnover.
The record since November 2023 is two falls of 15% or more in three years, the deepest 23%, which has not yet recovered. Median daily turnover was LKR 11.8 million, and a LKR 1 million order is about 8.5% of what trades on a typical day, a noticeable part of a day's trading. The 1:3 subdivision effective 29 December 2025 tripled the share count, so adjusted returns are the meaningful performance record and older per-share figures are not directly comparable.
Valuation
At 11.5 times P/E, the market pays LKR 11.5 for every LKR 1 of trailing profit, placing ACL at the 26th percentile of manufacturing-sector P/E readings. Its P/B of 1.83 means LKR 1.83 for each LKR 1 of net assets, near the sector middle at the 54th percentile; the audited March 2026 ROE of 17.2% provides the earnings return behind that book-value multiple.
The 0.6% dividend yield is at the 5th percentile among sector peers and is not the central part of the valuation case. The payout has nevertheless risen from LKR 0.417 in FY2024 to LKR 0.50 in FY2025 and LKR 0.60 in FY2026, albeit from a low payout ratio.
Against ACL's own record, its P/B is "more expensive than 89% of days since January 2019". A buyer at the current price is relying on a recent quarter that supplied 21.6% of trailing EPS; that quarter's net margin was below the year-ago level, although the same price would equate to 10.9 times earnings had that quarter retained the prior-year margin. The market-wide valuation score is 44 of 100 and classifies ACL as fairly valued, the starting point for the neutral stance.
News and sentiment
Direct coverage has been unusually heavy, with 12 material articles over 90 days, including 10 positive, versus ACL's normal monthly rate. This is a record of article tone and volume, not evidence of a change in operating performance.
The Employees' Provident Fund's holding was reported on 4 November as 10% of issued capital at 30 September, up from 9.6% in June. The first interim dividend of LKR 0.60 went ex-dividend on 7 October 2026, so a buyer today does not receive it. ACL was also added to the S&P SL20 effective 22 June; index inclusion does not alter the company's earnings power.
Financials
For the September 2026 quarter, revenue grew 26.3% year-on-year and operating profit rose 13.2%, but net profit increased only 1.2%. Gross margin was 23.8% versus 26.5% a year earlier, operating margin 18.0% versus 20.1%, and net margin 12.2% versus 15.3%. More sales therefore produced less profit from each rupee of revenue, and the profit a share is a claim on grew only marginally.
The September operating and net margins ranked fifth of seven comparable September quarters, a middling result on a like-for-like basis. LKR 823 million of costs below operating profit, including finance costs, tax, associates and foreign-exchange effects, further reduced the benefit of higher operating profit.
Equity rose to LKR 46.4 billion from LKR 39.5 billion year-on-year. Shares outstanding were 718.7 million at September 2026 versus 239.6 million a year earlier because of the completed 1:3 split, so the older reported EPS must not be read as a per-share earnings trend without restatement. These filed results end at 30 September 2026; no later company results are in the news supplied.
Risks
The leading financial-quality risk is cash conversion. In the audited year to March 2026, operating cash flow covered only 0.16 times operating profit, meaning much of the reported operating profit had not arrived as cash during that year. Free cash flow was still positive at LKR 1.1 billion, but the weaker conversion warrants attention alongside the subsequent growth in reported profit.
Balance-sheet liquidity is otherwise strong. Gearing, meaning debt against owners' equity, was 3.6%, while interest cover was 34.38 times, meaning operating profit covered the interest bill more than thirty times. The current ratio was 7.29 times, comparing short-term assets, including inventory and amounts owed by customers, with bills due within a year; ACL had substantially more such assets than near-term obligations.
Minority shareholders received 12.9% of FY2026 group profit, so group net profit is not entirely attributable to the ordinary shares being valued. Manufacturing conditions also carry input-cost risk: as at 15 November 2026, sector reporting pointed to higher energy and transport costs after fuel-price increases, while proposed trade-friction reductions and export measures remained policy initiatives rather than ACL-specific outcomes.
Outlook
As at 15 November 2026, the next identifiable company event is the interim filing for the quarter ending 31 December 2026, expected between 6 and 14 February 2027. It will show whether the September gap between strong revenue growth and subdued net-profit growth persisted, narrowed or widened.
The available data cannot establish current order intake, export demand or the effect of manufacturing input costs on ACL specifically. The next filing is therefore the first scheduled evidence that can update the September operating picture.